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DispatchesOf course, some evolutionary biologists
will ask for more data before they are
convinced of the generality of these
findings. First, other evolutionary
processes and interactions between
them may also contribute to species
cohesion (e.g., constraints from selection
and genetic drift) [19]. Second, the
genotypes at the color locus could not be
directly observed, limiting comparisons
between the color locus and SNP loci
used in the genome scan. Identification of
precise mutations under selection will be
required for a complete understanding of
the system. Yet, the genome scan was
only one of many avenues of the study
that supported the genetic bridge
hypothesis. Finally, better empirical
estimates of locus-specific migration
rates and selection coefficients under
different demographic scenarios will be
required to fully understand the
mechanism as well as the dynamics of
species boundaries [20]. The evidence
provided in walking sticks suggests that
anti-speciation phenotypes may very well
be a general phenomenon to be
considered in the quest for the origin of
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TDP-43 is a key disease protein for amyotrophic lateral sclerosis but
how it drives motor neuron degeneration remains unresolved. A new
study has modeled TDP-43 age-dependent axonal death in the
Drosophila leg and used a powerful forward genetic screen to identify
three novel suppressor genes.Amyotrophic lateral sclerosis (ALS) is a
neurodegenerative disease characterized
by adult-onset, progressive degeneration
of motor neurons, resulting in rapid
muscle weakness, paralysis, and death.
There is compelling evidence linking the
RNA-binding protein TDP-43 to ALS
pathogenesis. TDP-43 is the majorprotein comprising the insoluble,
ubiquitinated aggregates that are a
hallmark of ALS neuronal pathology [1]
and mutations in the gene encoding TDP-
43 can also cause ALS [2]. Although it is
clear that TDP-43 can regulate several
aspects of RNA processing [3], how a loss
of one or more of these functions, or
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Dispatchesperhaps a toxic gain-of-function, leads to
motor neuron degeneration is not fully
understood. Identifying modifiers of
toxicity in model organisms is a promising
path towards understanding TDP-43
pathophysiology and designing ALS
therapeutics. Such targets are sorely
needed, as there are currently no
therapeutic options to halt or significantly
slow ALS disease progression. A new
study by Sreedharan et al. [4] reported in
this issue of Current Biology has
described an improved system for
modeling age-dependent TDP-43 motor
neuron toxicity in Drosophila. Restricted
expression of ALS-linked mutant TDP-43
in single neurons of the leg in an otherwise
normal fly results in a ‘dying back’ of
axons similar to that observed in ALS
patients. Most importantly, the authors
harnessed the power of fly genetics with
an unbiased mutagenesis screen, finding
three genes that each suppress TDP-43
toxicity.
TDP-43 has been extensively studied
since the discovery in 2006 that it is
the main component of the insoluble
protein aggregates in ALS patient
motor neurons [1]. While TDP-43 is
predominantly localized to the nucleus in
healthy neurons, ALS patient neurons
show a characteristic nuclear clearing of
the protein accompanied by the formation
of cytoplasmic aggregates. Several lines
of evidence in multiple model organisms
have now demonstrated that cells
exquisitely regulate their levels of TDP-43,
such that both reduction of the protein or
its upregulation can result in cell death [3].
These experiments have led to both loss
and gain-of-function hypotheses
regarding TDP-43’s mechanism of
neuronal toxicity [3].
The fruit fly Drosophila melanogaster
has been used extensively to model the
effects of both loss of fly TDP-43 (dTDP-
43), encoded by the gene TBPH, and
overexpression of dTDP-43 or human
TDP-43 in the fly (reviewed in [5]). Well-
characterized driver lines have allowed
for TDP-43 levels to be altered within
specific, restricted types of cells. Several
models of neurodegeneration have been
developedwith overexpression of disease
proteins in the fly eye, given the ease of
observing its structural degenerative
phenotypes. Many studies have shown
that overexpression of human TDP-43 in
the fly eye results in an age- and dose-Curdependent degeneration [5]. Reduction or
overexpression of dTDP-43 in all fly
neurons or within larval or adult motor
neurons, the relevant cell type for ALS
patients, results in decreased locomotion
and adult lifespan [5]. Several groups have
reported disrupted synaptic morphology
and defective synaptic transmission when
TDP-43 levels are altered strictly within
motor neurons, suggesting that
endogenous TDP-43 may function to
regulate synaptic physiology [5].
The fruit fly has been an experimental
workhorse for groundbreaking studies
over the last century in both genetics
and neurobiology [6]. Naturally, the
development of somany different fly TDP-
43 models has facilitated several genetic
modifier screens. Microarrays, for
example, have been employed for the
unbiased detection of gene expression
changes caused by TDP-43
overexpression in the fly eye or in all
neurons. This approach led Zhan et al. to
find that decreased Notch signaling or
loss-of-function of fly nucleoporin Nup50
could increase the lifespan of transgenic
TDP-43 flies [7]. Tibbetts and colleagues
also used lifespan as a read-out to
perform a genetic screen for TDP-43
overexpression-induced motor neuron
toxicity. They performed the screen using
a collection of flies deficient for small
segments of each chromosome, finding
loss-of-function of wnd, the fly MAP3
kinase wallenda, extends the lifespan of
TDP-43 flies [8]. Further experiments
demonstrated that upregulation of TDP-
43 in motor neurons causes oxidative
stress, and the activation of innate
immunity genes and manipulating genes
within these pathways was sufficient to
modulate TDP-43 toxicity [8].
These unbiased genetic screening
approaches have illuminated potential
mechanisms of neuronal toxicity
associated with TDP-43, but have largely
relied on lifespan as a read-out for
modulation of toxicity, even in models
when TDP-43 expression is restricted to
motor neurons. This gross reduction in
lifespan has made it difficult to study
genes that can modulate the changes in
synaptic morphology and function
associated with TDP-43 overexpression
in adult flies. In this issue, Sreedharan
et al. describe a new fly model of TDP-43
toxicity that resolves some of the
limitations of previous models [4]. Theirrent Biology 25, R711–R731, August 17, 2015 ªmodel is novel in its ability to allow for
single motor neurons expressing TDP-43
to be monitored morphologically for
degeneration along with their
accompanying neuromuscular junctions
over several weeks in an otherwise
healthy fly (Figure 1). This task was
accomplished through the use of the
mosaic analysis with a repressible cell
marker (MARCM) system [9]. Freeman
and colleagues recently modified this tool
by incorporating genetically encoded
flippase (FLP) sources that drive mitotic
recombination very early in neuronal
lineages, thereby facilitating high
throughput screening. When combined
with GAL4 driver lines, transgene
expression can be limited to MARCM
clones within very few neurons of a
subtype. This allowed them to
discriminate the morphology of single
axons in the fly wing in an assay for injury-
induced axonal degeneration [10]. Here,
they report a similar MARCM approach
that allows for the expression of human
TDP-43 in only a few motor or sensory
neurons in the fly leg [4]. Axons and
neuromuscular junctions can also be
marked by expression of membrane-
tethered CD8–GFP, which was used
to score TDP-43-associated
neurodegeneration.
Sreedharan et al. found that expression
of both wild-type TDP-43 and the ALS-
linked mutant protein Q331K was
particularly toxic to motor neurons over
four weeks, with disruption of synaptic
morphology and loss of axonal integrity in
a ‘dying back’ fashion [4]. Directing
expression of their transgene to motor
neurons of the fly leg along with the
membrane-tethered GFP facilitated
microscopic preparation and analysis
and the ability to rapidly perform a
mutagenesis screen to identify genetic
modifiers of TDP-43 toxicity.
First, they used genetic manipulations
to demonstrate that TDP-43motor neuron
degeneration is distinct from Sarm1-
mediated active Wallerian degeneration
[4], a process that may occur in ALS
patient neurons [11]. Interestingly, this
finding appears to be in contrast with a
recent report in Caenorhabditis elegans
describing that TIR-1, the nematode
Sarm1 ortholog, acts downstream of
TDP-43 toxicity in neurons (although this
may not be a cell autonomous effect) [12],
and the finding that fly Wallenda, a2015 Elsevier Ltd All rights reserved R729
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Figure 1. The Drosophila leg as a model for TDP-43 toxicity.
(A) A diagram of the detached fly leg used by Sreedharan et al. for the analysis of leg motor neuron axons.
The MARCM technique allows for genetic manipulation and microscopic resolution of very few motor
neuron axons in the leg. Only these few axons have restricted expression of membrane-tethered GFP,
the mutant disease protein TDP-43, and can carry homozygous chemical-induced mutations in an
otherwise healthy fly. (B) A schematic of the MARCM strategy that was employed to achieve restricted
expression of transgenes in very few motor neurons in the fly leg. Flies are created that have motor
neuron-specific expression of the transcription factor Gal4, membrane-tethered CD8–GFP and mutant
TDP-43 under the control of Gal4-responsive UAS elements, and X chromosomes harboring FRT sites.
One X chromosome carries an EMS-induced mutation in a random gene and the other expresses
Gal80, a transcriptional regulator that inhibits transcriptional activation by Gal4. Nearly every motor
neuron in the fly will not express the TDP-43 and GFP transgenes due to the inhibition of Gal4 by
Gal80. However, during development some of the motor neuron progenitor cells will express flp
recombinase under the ase promoter. Flp will recombine the X chromosomes at the FRT sites in these
progenitors and when they undergo mitosis to become adult motor neurons some of these neurons will
lose the Gal80 transgene, releasing the inhibition of Gal4, which turns on the UAS-dependent
transcription of mutant TDP-43 and the membrane-tethered GFP to label axons and neuromuscular
junctions (NMJs). These GFP-labeled neurons will also be homozygous for the EMS-induced mutation,
allowing these genes to be tested as potential loss-of-function suppressors of TDP-43 toxicity. In the
future this genetic screening approach could be applied broadly to discover more modifiers of TDP-43
on other fly chromosomes and also extended to the study of other neurodegenerative disease
genes, such as FUS/TLS and C9orf72 in ALS, a-synuclein in Parkinson disease, mutant huntingtin in
Huntington disease, and tau and Ab in Alzheimer disease.
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regulator [13], can modify TDP-43
toxicity [8].
The authors then used the chemical
ethyl methanesulfonate (EMS) to generate
random mutations throughout the
genome and they focused on the X
chromosome to look for homozygous
mutations that could suppress TDP-43
motor neuron toxicity in MARCM axons
(Figure 1). They manually screened over
3,000 mutant lines under the microscope
and discovered five mutants that strongly
suppressed TDP-43 toxicity. Three ofR730 Current Biology 25, R711–R731, Augusthese were mutations in the same gene
and the other two were unique, resulting
in the final identification of three distinct
genes that suppress TDP-43 toxicity
when mutated [4]. One suppressor was
shaggy (sgg), the fly homolog of glycogen
synthase kinase-3, a known modifier of
neurodegenerative disease processes
[14]. Next, in three distinct mutant lines,
was a previously uncharacterized gene
they named hat-trick, because of its
similarity to the human heterochromatin-
associating proteins ARID4A/B and its
influence on TDP-43 toxicity (and perhapst 17, 2015 ª2015 Elsevier Ltd All rights reservedbecause this gene scored three times in
their screen). Last, the strongest
suppressor of TDP-43 mapped to the
gene xmas-2, a gene encoding a
component of a protein complex involved
in mRNA export.
While this study has uncovered three
novel and potent modifiers of TDP-43
motor neuron toxicity, further mechanistic
work remains for future study. Mutations
in sgg did not alter TDP-43 protein levels,
whereas mutations in hat-trick and
xmas-2 both reduced TDP-43 protein
expression and hint at possible post-
transcriptional effects specific to TDP-43.
Excitingly, future TDP-43 modifiers
await discovery, as the genetic
screen described here covered the
X chromosome, leaving 80% of the fly
genome yet to be screened. Furthermore,
this powerful fly leg motor neuron
screening platform described by
Sreedharan et al. can now be harnessed
to model the toxicity associated with a
multitude of other neurodegenerative
disease proteins in vivo in adult flies and,
in a larger context, to study genes that are
essential for motor neuron function and
survival.
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